[Evaluation of Estrovis 4000 (Quinestrol) as a lactation inhibitor in puerperium].
D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D009651:Norpregnatrienes / Q000494:pharmacology*; D049590:Postpartum Period; D011247:Pregnancy; D011800:Quinestrol / Q000494:pharmacology*
D009651:Norpregnatrienes; D011800:Quinestrol
Ocena przydatności preparatu Estrovis 4 000 (Quinestrol) dla celów hamowania laktacji w połogu.